Changes

Additional examples include:

Additional examples include:

*''Gahl v. Aurora Health Care, Inc.'', 977 N.W.2d 756, 782 (Wis. Ct. App. 2022) ("Throughout the October 12 hearing, the circuit court repeatedly questioned the parties to elicit additional information and greater detail. For example, the circuit court asked questions regarding the Food and Drug Administration's (FDA) position regarding ivermectin as a COVID-19 treatment.")

*''Gahl v. Aurora Health Care, Inc.'', 977 N.W.2d 756, 782 (Wis. Ct. App. 2022) ("Throughout the October 12 hearing, the circuit court repeatedly questioned the parties to elicit additional information and greater detail. For example, the circuit court asked questions regarding the Food and Drug Administration's (FDA) position regarding ivermectin as a COVID-19 treatment.").

*''Tex. Health Huguley, Inc. v. Jones'', 637 S.W.3d 202, 209 n.12 (Tex. App. 2021) ("The doctor explained that he had not prescribed Ivermectin while treating Mr. Jones's COVID-19 because the Food and Drug Administration (FDA) had issued a warning that the drug should not be used for COVID-19 treatment, and because, likely for the same reason, the drug was not part of Huguley's COVID-19 protocol.").

*''Tex. Health Huguley, Inc. v. Jones'', 637 S.W.3d 202, 209 n.12 (Tex. App. 2021) ("The doctor explained that he had not prescribed Ivermectin while treating Mr. Jones's COVID-19 because the Food and Drug Administration (FDA) had issued a warning that the drug should not be used for COVID-19 treatment, and because, likely for the same reason, the drug was not part of Huguley's COVID-19 protocol.").